{"id":7975,"date":"2025-01-27T21:22:00","date_gmt":"2025-01-28T02:22:00","guid":{"rendered":"https:\/\/stillcoviding.ca\/en\/?p=7975"},"modified":"2025-02-07T18:05:41","modified_gmt":"2025-02-07T23:05:41","slug":"vido-funded-24m-to-help-develop-holy-grail-coronavirus-vaccine","status":"publish","type":"post","link":"https:\/\/stillcoviding.ca\/en\/news\/vido-funded-24m-to-help-develop-holy-grail-coronavirus-vaccine\/","title":{"rendered":"VIDO funded $24M to help develop \u2018holy grail\u2019 coronavirus vaccine"},"content":{"rendered":"<p>The Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan has been awarded a $24 million grant to help develop a vaccine to protect against wide-ranging strains of coronaviruses.<\/p>\n<p>VIDO&#8217;s funding flows from Norwegian-based Coalition for Epidemic Preparedness Innovations (CEPI) into its ongoing development of its pan-sarbecovirus vaccine.<\/p>\n<p>Dr. Nicole Lurie, Executive Director of Emergency Preparedness at CEPI, said the vaccine is designed by combining fragments of several different coronaviruses into a single vaccine.<\/p>\n<p>VIDO&#8217;s goal is to develop a vaccine that would improve a person&#8217;s resistance to SARS-CoV-1 and SARS-CoV-2, the virus that led to the COVID-19 pandemic, as well as future coronaviruses, limiting how much resources are spent on new vaccines to match different strains of the virus.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan has been awarded a $24 million grant to help develop a vaccine to protect against wide-ranging strains of coronaviruses.<\/p>\n<p>VIDO&#8217;s funding flows from Norwegian-based Coalition for Epidemic Preparedness Innovations (CEPI) into its ongoing development of its pan-sarbecovirus vaccine.<\/p>\n<div class=\"more-link-wrapper\"><a class=\"more-link\" href=\"https:\/\/stillcoviding.ca\/en\/news\/vido-funded-24m-to-help-develop-holy-grail-coronavirus-vaccine\/\">Continue reading<span class=\"screen-reader-text\">VIDO funded $24M to help develop \u2018holy grail\u2019 coronavirus vaccine<\/span><\/a><\/div>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[96,18,8,14,362,1299,1123,15,1300],"class_list":["post-7975","post","type-post","status-publish","format-standard","hentry","category-news","tag-canada","tag-covid-19","tag-research","tag-sars-cov-2","tag-saskatchewan","tag-university-of-saskatchewan","tag-vaccine-and-infectious-disease-organization","tag-vaccines","tag-vido","entry"],"_links":{"self":[{"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/posts\/7975","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/comments?post=7975"}],"version-history":[{"count":2,"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/posts\/7975\/revisions"}],"predecessor-version":[{"id":7978,"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/posts\/7975\/revisions\/7978"}],"wp:attachment":[{"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/media?parent=7975"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/categories?post=7975"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/tags?post=7975"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}